Epratuzumab, a Humanized Anti-CD22 Antibody, in Aggressive Non-Hodgkin’s Lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Epratuzumab, a Humanized Anti-CD22 Antibody, in Aggressive Non-Hodgkin’s Lymphoma

Published:2004-08-15 Issue:16 Volume:10 Page:5327-5334
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Leonard John P.,Coleman Morton,Ketas Jamie C.,Chadburn Amy,Furman Richard,Schuster Michael W.,Feldman Eric J.,Ashe Michelle,Schuster Stephen J.,Wegener William A.,Hansen Hans J.,Ziccardi Heather,Eschenberg Michael,Gayko Urte,Fields Scott Z.,Cesano Alessandra,Goldenberg David M.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 210 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond Chemotherapy: Present and Future Perspectives in the Treatment of Lymphoproliferative Disorders;Biomedicines;2024-04-29

2. Challenges and strategies associated with CAR-T cell therapy in blood malignancies;Experimental Hematology & Oncology;2024-02-24

3. Pharmacology to Practice;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

4. Treatment strategies for relapse after CAR T-cell therapy in B cell lymphoma;Frontiers in Pediatrics;2024-01-12

5. New monoclonal antibodies for the treatment of acute lymphoblastic leukemia;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP